miRNAs in SARS-CoV-2 Infection: An Update
- PMID: 35319361
- DOI: 10.2174/1389200223666220321102824
miRNAs in SARS-CoV-2 Infection: An Update
Abstract
Coronavirus disease-2019 (COVID-19) is a highly infectious disease caused by newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the inception of SARS-CoV-2 in Wuhan, China, the virus has traveled more than 200 countries globally. The role of SARS-CoV-2 in COVID-19 has been thoroughly investigated and reviewed in the last 22 months or so; however, a comprehensive outline of miRNAs in SARS-CoV- 2 infection is still missing. The genetic material of SARS-CoV-2 is a single-stranded RNA molecule nearly 29 kb in size. RNA is composed of numerous sub-constituents RNA is found in the cells in a number of forms. including microRNAs (miRNAs). miRNAs play an essential role in biological processes like apoptosis, cellular metabolism, cell death, cell movement, oncogenesis, intracellular signaling, immunity, and infection. Lately, miRNAs have been involved in SARS-CoV-2 infection, though the clear demonstration of miRNAs in the SARS-CoV-2 infection is not fully elucidated. The present review article summarizes recent findings of miRNAs associated with SARS-CoV-2 infection. We presented various facets of miRNAs. miRNAs as the protagonists in viral infection, the occurrence of miRNA in cellular receptors, expression of miRNAs in multiple diseases, miRNA as a biomarker, and miRNA as a therapeutic tool have been discussed in detail. We also presented the vaccine status available in various countries.
Keywords: COVID-19; Coronavirus; SARS-CoV-2; acute respiratory syndrome; infection; miRNA.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.J Infect Public Health. 2022 Jul;15(7):788-799. doi: 10.1016/j.jiph.2022.06.012. Epub 2022 Jun 21. J Infect Public Health. 2022. PMID: 35751930 Free PMC article. Review.
-
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.Virus Res. 2022 Jan 15;308:198631. doi: 10.1016/j.virusres.2021.198631. Epub 2021 Nov 14. Virus Res. 2022. PMID: 34788642 Free PMC article. Review.
-
Circulating microRNAs as emerging regulators of COVID-19.Theranostics. 2023 Jan 1;13(1):125-147. doi: 10.7150/thno.78164. eCollection 2023. Theranostics. 2023. PMID: 36593971 Free PMC article. Review.
-
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1. Infect Genet Evol. 2021. PMID: 33812037 Free PMC article.
-
MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response.Cells. 2022 Jul 23;11(15):2279. doi: 10.3390/cells11152279. Cells. 2022. PMID: 35892576 Free PMC article. Review.
Cited by
-
Noncoding RNA, friend or foe for nephrolithiasis?Front Cell Dev Biol. 2024 Nov 20;12:1457319. doi: 10.3389/fcell.2024.1457319. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39633711 Free PMC article. Review.
-
SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease.Front Cell Neurosci. 2022 Jun 17;16:937961. doi: 10.3389/fncel.2022.937961. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35783095 Free PMC article. No abstract available.
-
Host combats porcine reproductive and respiratory syndrome virus infection at non-coding RNAs level.Virulence. 2024 Dec;15(1):2416551. doi: 10.1080/21505594.2024.2416551. Epub 2024 Oct 18. Virulence. 2024. PMID: 39403796 Free PMC article. Review.
-
Recovery From Long COVID: The Role of Bioelectric Meridian Therapy in Restoring Health and Well-Being.Cureus. 2024 Dec 23;16(12):e76279. doi: 10.7759/cureus.76279. eCollection 2024 Dec. Cureus. 2024. PMID: 39726863 Free PMC article.
-
Capecitabine regulates proliferation and apoptosis of ovarian cancer SKOV3 cells via the miR-29b-3p/MMP16 molecular axis.Am J Transl Res. 2024 Nov 15;16(11):7145-7154. doi: 10.62347/YGPG5971. eCollection 2024. Am J Transl Res. 2024. PMID: 39678594 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous